Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) changed -3.29% to recent value of $2.94. The stock transacted 126797 shares during most recent day however it has an average volume of 134.04K shares. It spotted trading -51.40% off 52-week high price. On the other end, the stock has been noted 26.90% away from the low price over the last 52-weeks.
On April 1, 2020, Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, is pleased to provide the following Letter to Shareholders from Chief Executive Officer Nadav Kidron.
As the world faces an unprecedented challenge with much uncertainty, we at Oramed wanted to provide our shareholders and other constituents with an update on our business. Over the past weeks, we have closely followed the guidance of governments and leading public health institutes to ensure the safety of our employees. Additionally, we have conducted a business review to assess the potential impact of COVID-19. At this time, we continue to move ahead with all strategic initiatives and anticipate limited long-term impact from COVID-19. As our platform technology could be effective for protein-based vaccines, we are closely monitoring developments on the efforts to find a vaccine for COVID-19 and any potential partnerships on this front.
ORMP has a gross margin of 98.00%. Its earnings per share (EPS) expected to touch remained 3.80% for this year.
The company has 23.72M of outstanding shares and 19.98M shares were floated in the market. According to the most recent quarter its current ratio was 6.6 that represents company’s ability to meet its current financial obligations. The price moved ahead of -7.08% from the mean of 20 days, -30.19% from mean of 50 days SMA and performed -22.63% from mean of 200 days price. Company’s performance for the week was -2.00%, -26.13% for month and YTD performance remained -42.91%.
Nathaniel worked as a reporter for an online news publication in China for two years, covering general city news; he also used to work for an international travel agency before pursuing a career in journalism. In his free time, Nathaniel enjoys outdoor recreation, following sports of all kinds. Nathaniel Schultz reports about Business category. Before joining Marketsnip.com, he worked as a news reporter for other publications, covering technology and health reporting. He earned his Master’s at School of Journalism, where he worked as a news reporter besides learning pertinent skills in magazine editing and interactive production.
He can be reached email at [email protected]
ADDRESS # 1454 West Wylie Street, Bloomington, IN 47403 USA
CONTACT # 423-808-5425